HHLR ADVISORS, LTD.
Institutional investor · Portfolio as of Q1 2021
Top Holdings91 positions
BEONE MEDICINES LTD | 5.5M | $1.9B | 18.8% | $136.90 | +154.27% | 10 qtrssince 2018-Q4 | Unchanged 0 |
PDD HOLDINGS INC | 10.2M | $1.4B | 13.5% | $34.21 | +291.35% | 10 qtrssince 2018-Q4 | Decreased 0 |
IQIYI INC | 38.6M | $642.3M | 6.3% | $18.39 | -6.42% | 10 qtrssince 2018-Q4 | Unchanged 0 |
ZOOM COMMUNICATIONS INC | 2M | $634.9M | 6.3% | $84.35 | +271.28% | 6 qtrssince 2019-Q4 | Decreased 0 |
ENSTAR GROUP LIMITED | 1.7M | $431.2M | 4.3% | — | — | 9 qtrssince 2019-Q1 | Unchanged 0 |
UBER TECHNOLOGIES INC | 6.8M | $370.2M | 3.7% | $29.72 | +79.88% | 7 qtrssince 2019-Q3 | Decreased 0 |
JD.COM INC | 4.2M | $351M | 3.5% | $44.76 | +68.25% | 10 qtrssince 2018-Q4 | Decreased 0 |
CHINA BIOLOGIC PRODUCTS HOLD | 3M | $350.7M | 3.5% | — | — | 10 qtrssince 2018-Q4 | Unchanged 0 |
BRIDGEBIO PHARMA INC | 5.4M | $330.3M | 3.3% | $28.25 | +109.24% | 8 qtrssince 2019-Q2 | Increased 65 |
I MAB | 6.6M | $320.7M | 3.2% | $45.18 | +4.40% | 3 qtrssince 2020-Q3 | Increased 92 |
KE HLDGS INC | 5M | $285.6M | 2.8% | $56.88 | -7.03% | 3 qtrssince 2020-Q3 | Increased 53 |
GDS HLDGS LTD | 3.1M | $254.9M | 2.5% | $80.16 | -0.47% | 4 qtrssince 2020-Q2 | Unchanged 0 |
SALESFORCE INC | 1.1M | $240.8M | 2.4% | $182.53 | +13.90% | 5 qtrssince 2020-Q1 | Increased 56 |
BILIBILI INC | 2M | $213.9M | 2.1% | $15.46 | +592.66% | 10 qtrssince 2018-Q4 | Decreased 0 |
APELLIS PHARMACEUTICALS INC | 4.6M | $195.6M | 1.9% | — | — | 10 qtrssince 2018-Q4 | Decreased 0 |
BEAM THERAPEUTICS INC | 2.1M | $165.9M | 1.6% | $18.00 | +344.67% | 5 qtrssince 2020-Q1 | Decreased 0 |
DOORDASH INC | 1.1M | $143.8M | 1.4% | $138.12 | -5.44% | 2 qtrssince 2020-Q4 | Increased 59 |
FIBROGEN INC | 4M | $137.3M | 1.4% | $1,096.52 | -20.86% | 10 qtrssince 2018-Q4 | Unchanged 0 |
MONDELEZ INTL INC | 1.9M | $109M | 1.1% | $33.70 | +54.60% | 10 qtrssince 2018-Q4 | Decreased 0 |
ARGENX SE | 375,540 | $103.4M | 1.0% | $216.75 | +25.61% | 6 qtrssince 2019-Q4 | Decreased 0 |
HHLR ADVISORS, LTD. manages $10.1B across 91 positions as of Q1 2021. Top holdings: ONC (18.8%), PDD (13.5%), IQ (6.3%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 2/5.0.
Active quarter - 13 new positions, 17 exits, 9 increased. Top move: NBP (INCREASED, conviction 92). Portfolio: $10.1B across 91 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
No active accumulation streaks detected for this filer.
Streaks require 2+ consecutive quarters of increased positions in the most recent period.
Continue exploring
Famous Investors' Portfolios
What the most-followed managers hold, and what they bought and sold each quarter.
- Warren Buffett (Chairman Emeritus)Berkshire Hathaway
- Leopold AschenbrennerSituational Awareness
- Michael BurryScion Asset Management
- Cathie WoodARK Invest
- Bill AckmanPershing Square
- Stanley DruckenmillerDuquesne Family Office
- David TepperAppaloosa
- Ray Dalio (Founder)Bridgewater Associates
- Li LuHimalaya Capital
- Carl IcahnCarl C. Icahn
- Brad GerstnerAltimeter Capital
- Seth KlarmanThe Baupost Group
- Howard Marks (Co‑founder)Oaktree Capital Management
- Ken GriffinCitadel
- Paul Tudor JonesTudor Investment Corp
- George Soros (Founder)Soros Fund Management
- Steve CohenPoint72
- Terry SmithFundsmith
- Ken Fisher (Founder)Fisher Investments
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR